Discovered how to predict whether patients with leukaemia will be sensitive to epigenetic drugs

Researchers from the Josep Carreras Leukaemia Research Institute, spearheaded by the Cancer Epigenetics group led by Dr. Manel Esteller, described the effects of chemotherapy at the single cell resolution in the bone marrow of Myelodysplastic Syndrome patients. The results help better understand which cellular populations are more sensitive to azacitidine, an epigenetic drug, and offer […]

Collaborate

This is Tooltip! I want become a member I want to donate I want become a member "*" señala los campos obligatorios Tipus d'usuari Particular Empresa Quan vols aportar?* 15€Col·labores amb la nostra unitat d’experimentació dedicada a un tipus de leucèmia infantil poc freqüent amb molt mal pronòstic. 30€Mantens els nostres pisos d’acollida per a […]

Contact

Inicio Contact us The Josep Carreras Leukaemia Foundation Muntaner 383, 2º. 08021, Barcelona, Spain (+34) 93 414 55 66 Fax: (+34) 93 201 05 88 Fax REDMO: (+34) 93 414 00 28 Fax: (+34) 93 201 05 88 Fax REDMO: (+34) 93 414 00 28 info@fcarreras.es Working hours Monday to Thursday from 8 a.m. to […]

Treatments

Treatments Inicio Chemotherapy Radiotherapy Biological therapy Haematopoietic progenitor-cell transplantation Clinical trials Extracorporeal photopheresis Become a member of the cure for leukaemia! BECOME A MEMBER! CHARITABLE INITIATIVES CHARITABLE BEQUESTS